-
公开(公告)号：US20070154483A1
公开(公告)日：2007-07-05
申请号：US11536881
申请日：2006-09-29
申请人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
发明人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
IPC分类号： A61K39/395 , A61K33/24 , A61K31/337 , A61K31/282
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20070148177A1
公开(公告)日：2007-06-28
申请号：US11537542
申请日：2006-09-29
申请人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
发明人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
IPC分类号： A61K39/395 , A61K31/7072 , A61K31/4745 , A61K31/282 , A61K31/337 , A61K33/24
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20070036753A1
公开(公告)日：2007-02-15
申请号：US11537310
申请日：2006-09-29
申请人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
发明人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
IPC分类号： A61K39/395 , A61K38/21 , A61K38/48 , A61K31/573 , A61K31/7048 , A61K31/522 , A61K31/513
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
摘要翻译： 本发明涉及一般用抗VEGF抗体治疗疾病和病理状况。 更具体地，本发明涉及使用抗VEGF抗体治疗对癌症敏感或诊断的人类，优选与一种或多种另外的抗肿瘤治疗剂组合。
-
公开(公告)号：US20070148178A1
公开(公告)日：2007-06-28
申请号：US11537560
申请日：2006-09-29
申请人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
发明人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
IPC分类号： A61K39/395 , A61K31/525 , A61K33/24
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20070036790A1
公开(公告)日：2007-02-15
申请号：US11537553
申请日：2006-09-29
申请人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
发明人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
IPC分类号： A61K39/395 , A61K38/21 , A61K31/7048 , A61K31/522 , A61K31/513 , A61K31/573 , A61K31/4745 , A61K31/557
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20070258984A1
公开(公告)日：2007-11-08
申请号：US11763263
申请日：2007-06-14
申请人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
发明人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
IPC分类号： A61K39/395 , A61P35/04
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20070036754A1
公开(公告)日：2007-02-15
申请号：US11537313
申请日：2006-09-29
申请人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
发明人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
IPC分类号： A61K39/395 , A61K38/21 , A61K31/56 , A61K31/525 , A61K38/48 , A61K31/522
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20070031413A1
公开(公告)日：2007-02-08
申请号：US11537281
申请日：2006-09-29
申请人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
发明人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
IPC分类号： A61K39/395 , A61K31/525 , A61K31/7072 , A61K31/282 , A61K31/4745 , A61K31/337 , A61K33/24
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20050186208A1
公开(公告)日：2005-08-25
申请号：US10857249
申请日：2004-05-28
申请人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
发明人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
IPC分类号： A61K31/4745 , A61K31/525 , A61K31/7072 , A61K39/395 , A61K45/06 , A61P35/00 , A61P35/04 , C07K16/22
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
摘要翻译： 本发明涉及一般用抗VEGF抗体治疗疾病和病理状况。 更具体地，本发明涉及使用抗VEGF抗体治疗对癌症敏感或诊断的人类，优选与一种或多种另外的抗肿瘤治疗剂组合。
-
公开(公告)号：US20070071749A1
公开(公告)日：2007-03-29
申请号：US11537543
申请日：2006-09-29
申请人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
发明人： Gwendolyn Fyfe , Eric Holmgren , Robert Mass , William Novotny
IPC分类号： A61K39/395 , A61K38/21 , A61K38/48 , A61K31/56 , A61K31/525 , A61K33/24 , A61K31/7072 , A61K31/7048
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
-
-
-
-
-
-
-
-
搜索结果
15 条记录 (耗时 0.039 秒)
